Recombinant mouse IL-17A protein (Active)
- Premium Bioactive
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Recombinant mouse IL-17A protein (Active) is a Mouse Full Length protein, in the 26 to 158 aa range, expressed in HEK 293 cells, with >95%, <0.005 EU/µg endotoxin level, suitable for SDS-PAGE, FuncS, Mass Spec, HPLC, Cell Culture.
View Alternative Names
Ctla8, Il17, Il17a, Interleukin-17A, IL-17, IL-17A, Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8
- FuncS
Supplier Data
Functional Studies - Recombinant mouse IL-17A protein (Active) (AB281805)
Functional analysis of ab281805.
Fully biologically active determined by the dose dependent induction of IL-6 secretion in NIH/3T3 cells. ED50 for this effect is ≤9.835 ng/mL, corresponding to a specific activity of 10.16 x 104 units/mg.
Cell based assay testing is performed on the first lot of protein only and is provided as a reference for protein activity; subsequent lots of protein must pass all biophysical quality control parameters that meet the same parameters as the first lot.
Lot : GR3387041-1
- Mass Spec
Supplier Data
Mass Spectrometry - Recombinant mouse IL-17A protein (Active) (AB281805)
Mass determination by ESI-TOF.
Predicted MW is 15035.21 Da. (+/- 10 Da by ESI-TOF). Observes MW is 15036.36 Da. Additional masses at 14965.35 is due to residual O-glycans.
- HPLC
Supplier Data
HPLC - Recombinant mouse IL-17A protein (Active) (AB281805)
HPLC analysis of ab281805.
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant mouse IL-17A protein (Active) (AB281805)
SDS-PAGE analysis of ab281805.
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Specifications
Form
Lyophilized
Additional notes
>=95% Purity by HPLC
General info
Function
Effector cytokine of innate and adaptive immune system involved in antimicrobial host defense and maintenance of tissue integrity (PubMed : 18025225, PubMed : 19144317, PubMed : 26431948). Signals via IL17RA-IL17RC heterodimeric receptor complex, triggering homotypic interaction of IL17RA and IL17RC chains with TRAF3IP2 adapter. This leads to downstream TRAF6-mediated activation of NF-kappa-B and MAPkinase pathways ultimately resulting in transcriptional activation of cytokines, chemokines, antimicrobial peptides and matrix metalloproteinases, with potential strong immune inflammation (PubMed : 16200068, PubMed : 17911633, PubMed : 19144317, PubMed : 26431948). Plays an important role in connecting T cell-mediated adaptive immunity and acute inflammatory response to destroy extracellular bacteria and fungi. As a signature effector cytokine of T-helper 17 cells (Th17), primarily induces neutrophil activation and recruitment at infection and inflammatory sites (PubMed : 18025225). In airway epithelium, mediates neutrophil chemotaxis via induction of CXCL1 and CXCL5 chemokines (PubMed : 18025225, PubMed : 27923703). In secondary lymphoid organs, contributes to germinal center formation by regulating the chemotactic response of B cells to CXCL12 and CXCL13, enhancing retention of B cells within the germinal centers, B cell somatic hypermutation rate and selection toward plasma cells (PubMed : 18157131). Effector cytokine of a subset of gamma-delta T cells that functions as part of an inflammatory circuit downstream IL1B, TLR2 and IL23A-IL12B to promote neutrophil recruitment for efficient bacterial clearance (PubMed : 17372004, PubMed : 20364087, PubMed : 28709803). Effector cytokine of innate immune cells including invariant natural killer cell (iNKT) and group 3 innate lymphoid cells that mediate initial neutrophilic inflammation (PubMed : 17470641, PubMed : 23255360). Involved in the maintenance of the integrity of epithelial barriers during homeostasis and pathogen infection. Upon acute injury, has a direct role in epithelial barrier formation by regulating OCLN localization and tight junction biogenesis (PubMed : 26431948). As part of the mucosal immune response induced by commensal bacteria, enhances host's ability to resist pathogenic bacterial and fungal infections by promoting neutrophil recruitment and antimicrobial peptides release (PubMed : 28709803). In synergy with IL17F, mediates the production of antimicrobial beta-defensins DEFB1, DEFB103A, and DEFB104A by mucosal epithelial cells, limiting the entry of microbes through the epithelial barriers (PubMed : 19144317). Involved in antiviral host defense through various mechanisms (PubMed : 21946434, PubMed : 26735852, PubMed : 27795421). Enhances immunity against West Nile virus by promoting T cell cytotoxicity (PubMed : 27795421). May play a beneficial role in influenza A virus (H5N1) infection by enhancing B cell recruitment and immune response in the lung (PubMed : 21946434). Contributes to influenza A virus (H1N1) clearance by driving the differentiation of B-1a B cells, providing for production of virus-specific IgM antibodies at first line of host defense (PubMed : 26735852).
Sequence similarities
Belongs to the IL-17 family.
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Viruses 17: PubMed40006939
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com